Insider Transactions in Q1 2022 at Jounce Therapeutics, Inc. (JNCE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Elizabeth Trehu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+19.61%
|
-
|
|
Feb 01
2022
|
Richard /Ca/ Murray Director |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+24.27%
|
-
|
|
Feb 01
2022
|
Kimberlee C Drapkin President, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+25.55%
|
-
|
|
Feb 01
2022
|
Hugh M Cole Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+28.48%
|
-
|
|
Jan 10
2022
|
Hugh M Cole Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,205
-8.81%
|
$37,230
$6.65 P/Share
|
|
Jan 10
2022
|
Kimberlee C Drapkin President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
8,222
-13.52%
|
$49,332
$6.65 P/Share
|
|
Jan 10
2022
|
Richard /Ca/ Murray Director |
SELL
Open market or private sale
|
Direct |
23,924
-11.42%
|
$143,544
$6.65 P/Share
|
|
Jan 10
2022
|
Elizabeth Trehu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,378
-5.94%
|
$32,268
$6.65 P/Share
|
|
Jan 07
2022
|
Hugh M Cole Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,468
-4.69%
|
$24,276
$7.3 P/Share
|
|
Jan 07
2022
|
Kimberlee C Drapkin President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
4,595
-7.02%
|
$32,165
$7.3 P/Share
|
|
Jan 07
2022
|
Richard /Ca/ Murray Director |
SELL
Open market or private sale
|
Direct |
13,370
-6.0%
|
$93,590
$7.3 P/Share
|
|
Jan 07
2022
|
Elizabeth Trehu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,005
-3.21%
|
$21,035
$7.3 P/Share
|